These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21220770)

  • 21. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.
    Diallo K; Zheng DP; Rottinghaus EK; Bassey O; Yang C
    AIDS Res Hum Retroviruses; 2015 May; 31(5):564-75. PubMed ID: 25582324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
    Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
    Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya.
    Lihana RW; Khamadi SA; Lubano K; Mwangi J; Kinyua JG; Okoth VO; Lagat NJ; Okoth FA; Songok EM; Makokha EP
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):833-8. PubMed ID: 20624074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
    Kroon E; Pham PT; Sirivichayakul S; Trichavaroj R; Colby DJ; Pinyakorn S; Phanuphak N; Sanders-Buell E; van Griensven F; Kijak GH; Kim JH; Michael NL; Robb ML; Ananworanich J; De Souza MS; Tovanabutra S;
    AIDS; 2018 Oct; 32(16):2373-2381. PubMed ID: 30096068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam.
    Phan TT; Ishizaki A; Phung DC; Bi X; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):233-5. PubMed ID: 20156106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil.
    de Castro CA; Grinsztejn B; Veloso VG; Bastos FI; Pilotto JH; Morgado MG
    BMC Infect Dis; 2010 Jul; 10():224. PubMed ID: 20667113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal.
    Bhusal N; Sutthent R; Horthongkham N; Athipanyasilp N; Kantakamalakul W
    Curr HIV Res; 2016; 14(6):517-524. PubMed ID: 27697032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.
    Hamers RL; Siwale M; Wallis CL; Labib M; van Hasselt R; Stevens WS; Schuurman R; Wensing AM; Van Vugt M; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):95-101. PubMed ID: 20585262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and molecular characterization of urinary tract HIV-1 populations.
    Mzingwane ML; Hunt G; Lassauniere R; Kalimashe M; Bongwe A; Ledwaba J; Chaisson RE; Martinson N; Richter K; Bowyer SM; Tiemessen CT
    Ann Clin Microbiol Antimicrob; 2019 Sep; 18(1):27. PubMed ID: 31551072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa.
    Caron M; Makuwa M; Souquière S; Descamps D; Brun-Vézinet F; Kazanji M
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1225-8. PubMed ID: 18788914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden.
    Andersson E; Nordquist A; Esbjörnsson J; Flamholc L; Gisslén M; Hejdeman B; Marrone G; Norrgren H; Svedhem V; Wendahl S; Albert J; Sönnerborg A
    AIDS; 2018 Apr; 32(7):877-884. PubMed ID: 29369826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Characterization of HIV-1 Minority Subtypes in Hong Kong: A Recent Epidemic of CRF07_BC among the Men who have Sex with Men Population.
    Leung KS; To SW; Chen JH; Siu GK; Chan KC; Yam WC
    Curr HIV Res; 2019; 17(1):53-64. PubMed ID: 31142258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
    Sprinz E; Netto EM; Patelli M; Lima JS; Furtado JJ; da Eira M; Zajdenverg R; Madruga JV; Lewi DS; Machado AA; Pedro RJ; Soares MA
    AIDS Res Hum Retroviruses; 2009 Sep; 25(9):861-7. PubMed ID: 19689190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.